Xeris Biopharma XERS Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates RFIL Q1 2026 Earnings Strong EPS Surprise Drives Share Gains Despite Limited Revenue Disclosure IBOC Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement SLDB Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Advances Pipeline LULU Q1 2026 Earnings EPS Beats Estimates Amid Modest Stock Uptick Federated Hermes Inc FHI Q1 2026 Earnings EPS Surpasses Estimates by 63